Premium
Effect of beclomethasone dipropionate nasal aerosol on serum markers of bone metabolism in children with seasonal allergic rhinitis
Author(s) -
MARTINATI L. C.,
SETTE L.,
CHIOCCA E.,
ZANINOTTO M.,
PLEBANI M.,
BONER A. L.
Publication year - 1993
Publication title -
clinical and experimental allergy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.462
H-Index - 154
eISSN - 1365-2222
pISSN - 0954-7894
DOI - 10.1111/j.1365-2222.1993.tb00288.x
Subject(s) - medicine , bone remodeling , parathyroid hormone , endocrinology , osteocalcin , alkaline phosphatase , n terminal telopeptide , bone ash , nasal spray , chemistry , immunology , nasal administration , calcium , biochemistry , enzyme
Summary Thirty‐nine children with grass pollen hay fever were randomly treated with nasal inhaled beclomethasone dipropionate (BDP) 200 or 400μg‘day or sodium cromoglycate (SCG) 30 ing/day for 2 months during the pollen season. Scrum osteocalcin (OC), parathyroid hormone (PTH). total alkaline phosphatase (AP). hone alkaline phosphatase (BAP) and type I collagen telopcptide (ICTP) were measured immediately before, I and 2 months after treatment and 1 week after stopping the therapy. No significant changes in OC, PTH, AP, BAP and ICTP serum level occurred within each group. Minor and probably clinically insignificant between group differences were occasionally found. Our study shows that BDP nasal spray has no significant effect on common markers of bone metabolism.